Vaughan Nelson Investment Management L.P. Boosts Stake in Nutrien Ltd. (NYSE:NTR)

Vaughan Nelson Investment Management L.P. lifted its holdings in shares of Nutrien Ltd. (NYSE:NTR) by 71.7% in the fourth quarter, HoldingsChannel.com reports. The firm owned 74,055 shares of the company’s stock after acquiring an additional 30,925 shares during the quarter. Vaughan Nelson Investment Management L.P.’s holdings in Nutrien were worth $3,314,000 at the end of the most recent quarter.

Other hedge funds and other institutional investors have also recently modified their holdings of the company. HHM Wealth Advisors LLC lifted its position in Nutrien by 331.0% in the fourth quarter. HHM Wealth Advisors LLC now owns 625 shares of the company’s stock valued at $28,000 after buying an additional 480 shares during the last quarter. Exchange Traded Concepts LLC lifted its holdings in shares of Nutrien by 96.7% in the 4th quarter. Exchange Traded Concepts LLC now owns 846 shares of the company’s stock worth $38,000 after acquiring an additional 416 shares during the last quarter. Union Bancaire Privee UBP SA acquired a new position in shares of Nutrien in the 4th quarter worth approximately $67,000. Larson Financial Group LLC boosted its position in shares of Nutrien by 1,370.6% during the 3rd quarter. Larson Financial Group LLC now owns 1,603 shares of the company’s stock worth $77,000 after purchasing an additional 1,494 shares during the period. Finally, Cromwell Holdings LLC increased its holdings in Nutrien by 113.4% in the 3rd quarter. Cromwell Holdings LLC now owns 1,694 shares of the company’s stock valued at $82,000 after purchasing an additional 900 shares during the last quarter. 63.10% of the stock is owned by institutional investors and hedge funds.

Analyst Upgrades and Downgrades

A number of research analysts have commented on NTR shares. TD Securities decreased their price target on Nutrien from $63.00 to $61.00 and set a “buy” rating on the stock in a research note on Tuesday, November 12th. Wells Fargo & Company increased their target price on Nutrien from $52.00 to $53.00 and gave the stock an “equal weight” rating in a research note on Tuesday, January 28th. Oppenheimer assumed coverage on Nutrien in a research report on Thursday, December 12th. They issued an “outperform” rating and a $60.00 target price for the company. Barclays reissued an “equal weight” rating and set a $56.00 price target (up previously from $55.00) on shares of Nutrien in a research report on Tuesday, January 21st. Finally, JPMorgan Chase & Co. upgraded shares of Nutrien from an “underweight” rating to a “neutral” rating and lifted their price objective for the company from $40.00 to $50.00 in a report on Monday, January 13th. One investment analyst has rated the stock with a sell rating, six have assigned a hold rating and ten have issued a buy rating to the stock. Based on data from MarketBeat.com, the company has an average rating of “Moderate Buy” and an average price target of $58.94.

Nutrien Stock Performance

NYSE:NTR opened at $50.32 on Monday. Nutrien Ltd. has a 12 month low of $43.69 and a 12 month high of $60.87. The company has a debt-to-equity ratio of 0.38, a current ratio of 1.27 and a quick ratio of 0.82. The firm has a market capitalization of $24.71 billion, a PE ratio of 33.77, a price-to-earnings-growth ratio of 1.13 and a beta of 0.81. The business’s fifty day moving average price is $48.73 and its 200 day moving average price is $48.10.

Nutrien Company Profile

Nutrien Ltd. provides crop inputs and services. The company operates through four segments: Retail, Potash, Nitrogen, and Phosphate. The Retail segment distributes crop nutrients, crop protection products, seeds, and merchandise products. The Potash segment provides granular and standard potash products.